Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 2/2021

01-08-2021 | Anticoagulant

Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients

Authors: Gwendolyn Ho, Jennifer R. Dusendang, Julie Schmittdiel, Juraj Kavecansky, Jahan Tavakoli, Ashok Pai

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2021

Login to get access

Excerpt

  • We evaluated clinical outcomes in over 28,000 SARS-CoV-2 infected patients.
  • We did not find an association between chronic antiplatelet and anticoagulant use with reduced risk of hospitalization, mechanical ventilation, thrombosis or mortality.
…
Literature
1.
Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135(23):2033–2040CrossRef
2.
Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147CrossRef
3.
Wichmann D, Sperhake JP, Lütgehetmann M et al (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 173(4):268–277CrossRef
4.
Bikdeli B, Madhavan MV, Jimenez D et al (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 75(23):2950–2973CrossRef
5.
Barnes GD, Burnett A, Allen A et al (2020) Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis 50(1):72–81CrossRef
6.
Barrett CD, Moore HB, Yaffe MB, Moore EE (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment. J Thromb Haemost 18(8):2060–2063CrossRef
7.
Tremblay D, van Gerwen M, Alsen M et al (2020) Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study. Blood 136(1):144–147CrossRef
8.
9.
Gupta S, Hayek SS, Wang W et al (2020) (2020) Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 180:1–12CrossRef
10.
Price-Haywood EG, Burton J, Fort D, Seoane L (2020) Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med 382(26):2534–2543CrossRef
11.
Suleyman G, Fadel RA, Malette KM et al (2020) Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw Open 3(6):e2012270CrossRef
12.
Lighter J, Phillips M, Hochman S et al (2020) Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis 71(15):896–897CrossRef
Metadata
Title
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
Authors
Gwendolyn Ho
Jennifer R. Dusendang
Julie Schmittdiel
Juraj Kavecansky
Jahan Tavakoli
Ashok Pai
Publication date
01-08-2021
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-021-02383-w

Other articles of this Issue 2/2021

Journal of Thrombosis and Thrombolysis 2/2021 Go to the issue

Report

Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19

ReviewPaper

Factor Xa: Thrombokinase from Paul Morawitz to J Haskell Milstone

ReviewPaper

Prothrombinase: the paradigm for membrane bound enzyme complexes; a memoir

OriginalPaper

Management of isolated distal deep–vein thrombosis with direct oral anticoagulants in the RIETE registry

OriginalPaper

Roles of factor Xa beyond coagulation

ReviewPaper

Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits